<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90746">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01945853</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00080565</org_study_id>
    <nct_id>NCT01945853</nct_id>
  </id_info>
  <brief_title>Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)</brief_title>
  <official_title>Imaging Myelin Injury in Amyotrophic Lateral Sclerosis (ALS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to identify the degree of grey and white matter involvement in
      patients with Amyotrophic Lateral Sclerosis (ALS) utilizing non-invasive techniques. The
      imaging to be utilized will be the 7 Tesla (7T) magnetic resonance imaging (MRI) of the
      brain. These results will be correlated to the ALS Functional Rating Scale - Revised
      (ALSFRS-R) score to assess if any changes in MRI can be predictive in the disability of the
      ALS patients at baseline and at 6 month intervals. The participants will be asked to return
      every 6 months for a neurological examination, ALSFRS-R assessment, measurement of the vital
      capacity and MRI as outlined above to monitor progression of the disease.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>MRI Changes in ALS Patients Vs Healthy Controls</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Voxel Based Morphometry will be utilized to look for any changes in the MRI results comparing ALS subjects to healthy volunteers.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MRI Changes in ALS Patients</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Voxel Based Morphometry will be utilized to look for any changes in the MRI results comparing ALS subjects comparing ALS subjects of differing clinical severity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Amyotrophic Lateral Sclerosis (ALS)</condition>
  <arm_group>
    <arm_group_label>7 Tesla MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>7T MRI will be done on ALS patients at baseline and at 6 month intervals.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>7 Tesla MRI</intervention_name>
    <arm_group_label>7 Tesla MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and Females who are 18 - 80 years old.

          -  The participants will meet the standard diagnostic criteria for possible or probable
             ALS (based on El Escorial criteria). They will have been diagnosed by a Johns Hopkins
             Neurologist.

          -  Healthy controls will be recruited by their interest in assisting the ALS population.

        Exclusion Criteria:

          -  Forced vital capacity less than 60 % of predicted value.

          -  Documented orthopnea on ALSFRS-R or otherwise unable to lie flat in an MRI scanner
             for the duration of the study.

          -  Presence of pacemakers, aneurysm clips, shrapnel or otherwise disallowed implanted
             metallic devices for obtaining an MRI scan.

          -  Pregnant or lactating females

          -  Glomerular filtration rate (GFR) less than 60

          -  History of: encephalitis, extensive white matter disease, intracranial hemorrhage,
             cerebral palsy, allergy to dye and/or IV drug abuse.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey D Rothstein, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 15, 2014</lastchanged_date>
  <firstreceived_date>September 16, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Dr. Jeffrey Rothstein</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
